Lisa Svartdal Normann
2PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Jan 27, 2023
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.Lisa Svartdal Normann, Mads Haugland Haugen, Vesa Hongisto
|Mar 08, 2022
miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy.Lisa Svartdal Normann, Mads Haugland Haugen, Miriam Ragle Aure
Pageof 1
